Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-02

Clinical Trial Update: MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen [Phase 2]

View source ↗

Summary

Phase 2 randomized trial comparing Avastin (bevacizumab) alone or with Macugen (pegaptanib) versus Macugen alone for macular degeneration. The study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avastin (bevacizumab)
  • Macugen (pegaptanib sodium)

Snippet

Sponsor: The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | Conditions: Macular Degeneration | Phase 2 | Status: COMPLETED